Coronavirus Update

Novel Coronavirus SARS-CoV-2, the agent responsible for coronavirus disease 2019 (COVID-19), is producing a growing public health emergency in China and elsewhere in the world.  As the numbers of confirmed cases and deaths continue to rise, clinical details of COVID-19 disease have become available through case reports and public health partners. However, the complete clinical spectrum is not yet fully understood, and health care providers may not be familiar with the most recent information related to the clinical course, diagnostic tests, and state of treatment strategies for this infection. There is also a need to educate health care providers on the key measures that hospitals and clinics can utilize to prepare for handling Persons Under Investigation (PUI) and reduce exposure of healthcare personnel as well as others. This activity aims to update health care providers regarding the state of the epidemiology, diagnosis, clinical course, and state of treatment strategies for COVID-19 disease caused by the SARS-CoV-2 virus. The activity also aims to provide health care providers with guidance on handling PUI to reduce the risk of transmission.    

Target Audience

This CME/CE activity is designed to meet the educational needs of Physicians, Advanced Practice Professionals, Fellows, Residents, Nurses, and Other Health Professionals

Learning Objectives

    At the conclusion of the session, the participants should be able to:

    • Identify patients who should be evaluated as patients under investigation for SARS-CoV-2 infection
    • Incorporate the appropriate procedures for patient isolation, handling and diagnostic testing for patients with suspected COVID-19 disease caused by SARS-CoV-2 infection in their clinics
    • Describe the state of the recommended treatment and supportive care strategies for patients with confirmed COVID-19 disease
    • Discuss drugs and vaccines in development against the SARS-Cov-2 virus
    Course summary
    Available credit: 
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Attendance
    Course opens: 
    01/31/2020
    Course expires: 
    02/28/2021
    Rating: 
    0

    Mayar Al Mohajer, M.D.
    Associate Professor
    Department of Medicine, Infectious Disease
    Baylor College of Medicine
    Houston, Texas
    Disclosure: Nothing to disclose

    Robert Legare Atmar, M.D., Peer Reviewer
    Professor
    Department of Medicine, Infectious Disease
    Baylor College of Medicine
    Houston, Texas
    Disclosure: Takeda Vaccines, Inc – Research support
    Seres Therapeutics, Inc – Data Monitoring Committee

    Maria Elena Bottazzi, Ph.D.
    Associate Dean, National School of Tropical Medicine
    Professor, Departments of Pediatrics, Molecular Virology & Microbiology
    Baylor College of Medicine
    Disclosure: Nothing to Disclose

    Peter Hotez, M.D., Ph.D.
    Dean, National School of Tropical Medicine
    Professor, Departments of Pediatrics, Molecular Virology & Microbiology
    Co-Head, Section of Pediatric Tropical Medicine
    Health Policy Scholar
    Baylor College of Medicine
    Disclosure: Nothing to Disclose

    David McCormick, M.D.
    Resident
    Department of Medicine, Infectious Disease
    Baylor College of Medicine
    Houston, Texas
    Disclosure: Nothing to Disclose

    Amy Spallone, M.D.
    Fellow
    Department of Medicine, Infectious Disease
    Baylor College of Medicine
    Houston, Texas
    Disclosure: Nothing to Disclose

    Laila Eugenia Woc-Colburn, M.D., Program Director
    Associate Professor
    Department of Medicine, Infectious Disease
    Director of Medical Education
    National School of Tropical Medicine
    Baylor College of Medicine
    Houston, Texas
    Disclosure: McGraw Hill, Elsevier – Intellectual property
    ASTMH, ISDA – Honorarium recipient

    Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Baylor College of Medicine designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Available Credit

    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Attendance
    Please login or register to take this course.

    Required Hardware/software

    Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.